Global mRNA Platform Market by Indication (Autoimmune Diseases, Cancer, Infectious Diseases), Usability (Prophylactic Vaccines, Therapeutic Drugs, Therapeutic Vaccines), mRNA Type, End-User - Forecast 2024-2030- Product Image

Sale

Global mRNA Platform Market by Indication (Autoimmune Diseases, Cancer, Infectious Diseases), Usability (Prophylactic Vaccines, Therapeutic Drugs, Therapeutic Vaccines), mRNA Type, End-User - Forecast 2024-2030

Report
192 Pages
March 2024
Region: Global
360iResearch™
ID: 5460245

UP TO €844EUR$875USD£724GBP OFF until Dec 31^st 2024

The mRNA Platform Market size was estimated at USD 8.40 billion in 2023, USD 11.73 billion in 2024, and is expected to grow at a CAGR of 51.63% to reach USD 154.82 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the mRNA Platform Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the mRNA Platform Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the mRNA Platform Market, highlighting leading vendors and their innovative profiles. These include Argos Therapeutics, Inc., AstraZeneca plc., BioNTech SE, CRISPR Therapeutics AG, CureVac N.V., Dicerna Pharmaceuticals, Inc by Novo Nordisk A/S, eTheRNA, ethris GmbH, In-Cell-Art, Merck & Co., Inc., Moderna, Inc., Pfizer Inc., Regulus Therapeutics Inc., Sangamo Therapeutics, Inc., Sanofi S.A., and Tiba Biotech LLC.

Market Segmentation & Coverage

This research report categorizes the mRNA Platform Market to forecast the revenues and analyze trends in each of the following sub-markets:

Indication
- Autoimmune Diseases
- Cancer
  - Personalized Treatment
  - Single Cancer Focussed
- Infectious Diseases
- Rare Diseases
- Respiratory Diseases
Usability
- Prophylactic Vaccines
- Therapeutic Drugs
- Therapeutic Vaccines
mRNA Type
- Nucleoside-Modified mRNA
- Self-Amplifying mRNA
- Unmodified mRNA
End-User
- Hospitals & Clinics
- Pharmaceutical Companies
- Research Organization

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the mRNA Platform Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the mRNA Platform Market?
What are the technology trends and regulatory frameworks in the mRNA Platform Market?
What is the market share of the leading vendors in the mRNA Platform Market?
Which modes and strategic moves are suitable for entering the mRNA Platform Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. mRNA Platform Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Significant mRNA advantages over other vaccine modalities
5.1.1.2. Developing therapeutic cancer treatment, exploiting mRNA platform
5.1.1.3. Need to reduce vaccine development and commercialization timeline
5.1.2. Restraints
5.1.2.1. Complexity in optimising manufacturing and commercial pathways
5.1.3. Opportunities
5.1.3.1. Increased market capitalization and public funding
5.1.3.2. mRNA technology optimization on development of on-demand vaccines
5.1.3.3. Increased development in prophylactic vaccines and therapeutic vaccines
5.1.4. Challenges
5.1.4.1. High clinical and regulatory risk
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. mRNA Platform Market, by Indication

6.1. Introduction
6.2. Autoimmune Diseases
6.3. Cancer
6.4.1. Personalized Treatment
6.4.2. Single Cancer Focussed
6.4. Infectious Diseases
6.5. Rare Diseases
6.6. Respiratory Diseases

7. mRNA Platform Market, by Usability

7.1. Introduction
7.2. Prophylactic Vaccines
7.3. Therapeutic Drugs
7.4. Therapeutic Vaccines

8. mRNA Platform Market, by mRNA Type

8.1. Introduction
8.2. Nucleoside-Modified mRNA
8.3. Self-Amplifying mRNA
8.4. Unmodified mRNA

9. mRNA Platform Market, by End-User

9.1. Introduction
9.2. Hospitals & Clinics
9.3. Pharmaceutical Companies
9.4. Research Organization

10. Americas mRNA Platform Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific mRNA Platform Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa mRNA Platform Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. Argos Therapeutics, Inc.
14.1.2. AstraZeneca plc.
14.1.3. BioNTech SE
14.1.4. CRISPR Therapeutics AG
14.1.5. CureVac N.V.
14.1.6. Dicerna Pharmaceuticals, Inc by Novo Nordisk A/S
14.1.7. eTheRNA
14.1.8. ethris GmbH
14.1.9. In-Cell-Art
14.1.10. Merck & Co., Inc.
14.1.11. Moderna, Inc.
14.1.12. Pfizer Inc.
14.1.13. Regulus Therapeutics Inc.
14.1.14. Sangamo Therapeutics, Inc.
14.1.15. Sanofi S.A.
14.1.16. Tiba Biotech LLC
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. MRNA PLATFORM MARKET RESEARCH PROCESS
FIGURE 2. MRNA PLATFORM MARKET SIZE, 2023 VS 2030
FIGURE 3. MRNA PLATFORM MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. MRNA PLATFORM MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. MRNA PLATFORM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. MRNA PLATFORM MARKET DYNAMICS
FIGURE 7. MRNA PLATFORM MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 8. MRNA PLATFORM MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. MRNA PLATFORM MARKET SIZE, BY USABILITY, 2023 VS 2030 (%)
FIGURE 10. MRNA PLATFORM MARKET SIZE, BY USABILITY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2023 VS 2030 (%)
FIGURE 12. MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. MRNA PLATFORM MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. MRNA PLATFORM MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES MRNA PLATFORM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES MRNA PLATFORM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. MRNA PLATFORM MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. MRNA PLATFORM MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. MRNA PLATFORM MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. MRNA PLATFORM MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MRNA PLATFORM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 6. MRNA PLATFORM MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. MRNA PLATFORM MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 9. MRNA PLATFORM MARKET SIZE, BY PERSONALIZED TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. MRNA PLATFORM MARKET SIZE, BY SINGLE CANCER FOCUSSED, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. MRNA PLATFORM MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. MRNA PLATFORM MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. MRNA PLATFORM MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 15. MRNA PLATFORM MARKET SIZE, BY PROPHYLACTIC VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. MRNA PLATFORM MARKET SIZE, BY THERAPEUTIC VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 19. MRNA PLATFORM MARKET SIZE, BY NUCLEOSIDE-MODIFIED MRNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. MRNA PLATFORM MARKET SIZE, BY SELF-AMPLIFYING MRNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. MRNA PLATFORM MARKET SIZE, BY UNMODIFIED MRNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 23. MRNA PLATFORM MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. MRNA PLATFORM MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. MRNA PLATFORM MARKET SIZE, BY RESEARCH ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. CANADA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 43. CANADA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 44. CANADA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 45. CANADA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 46. CANADA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. MEXICO MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 48. MEXICO MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 49. MEXICO MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 50. MEXICO MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 51. MEXICO MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES MRNA PLATFORM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. CHINA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 70. CHINA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 71. CHINA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 72. CHINA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 73. CHINA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. INDIA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. INDIA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 76. INDIA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 77. INDIA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 78. INDIA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. JAPAN MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. JAPAN MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 86. JAPAN MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 87. JAPAN MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 88. JAPAN MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. THAILAND MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. THAILAND MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 116. THAILAND MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 117. THAILAND MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 118. THAILAND MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA MRNA PLATFORM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 130. DENMARK MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 131. DENMARK MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 132. DENMARK MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 133. DENMARK MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 134. DENMARK MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. EGYPT MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 136. EGYPT MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 137. EGYPT MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 138. EGYPT MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 139. EGYPT MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. FINLAND MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 141. FINLAND MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 142. FINLAND MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 143. FINLAND MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 144. FINLAND MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. FRANCE MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 146. FRANCE MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 147. FRANCE MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 148. FRANCE MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 149. FRANCE MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. GERMANY MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 151. GERMANY MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 152. GERMANY MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 153. GERMANY MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 154. GERMANY MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. ITALY MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 161. ITALY MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 162. ITALY MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 163. ITALY MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 164. ITALY MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. NORWAY MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 176. NORWAY MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 177. NORWAY MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 178. NORWAY MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 179. NORWAY MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. POLAND MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 181. POLAND MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 182. POLAND MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 183. POLAND MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 184. POLAND MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. QATAR MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 186. QATAR MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 187. QATAR MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 188. QATAR MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 189. QATAR MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 205. SPAIN MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 206. SPAIN MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 207. SPAIN MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 208. SPAIN MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 209. SPAIN MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 220. TURKEY MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 221. TURKEY MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 222. TURKEY MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 223. TURKEY MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 224. TURKEY MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY MRNA TYPE, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM MRNA PLATFORM MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. MRNA PLATFORM MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 236. MRNA PLATFORM MARKET SHARE, BY KEY PLAYER, 2023
TABLE 237. MRNA PLATFORM MARKET LICENSE & PRICING

Companies Mentioned

Argos Therapeutics, Inc.
AstraZeneca plc.
BioNTech SE
CRISPR Therapeutics AG
CureVac N.V.
Dicerna Pharmaceuticals, Inc by Novo Nordisk A/S
eTheRNA
ethris GmbH
In-Cell-Art
Merck & Co., Inc.
Moderna, Inc.
Pfizer Inc.
Regulus Therapeutics Inc.
Sangamo Therapeutics, Inc.
Sanofi S.A.
Tiba Biotech LLC

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	192
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 11.73 Billion
Forecasted Market Value ( USD ) by 2030	$ 154.82 Billion
Compound Annual Growth Rate	51.6%
Regions Covered	Global
No. of Companies Mentioned	16

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3257EUR$3,374USD£2,794GBP €3619EUR$3,749USD£3,104GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4125EUR$4,274USD£3,539GBP €4584EUR$4,749USD£3,932GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4994EUR$5,174USD£4,284GBP €5549EUR$5,749USD£4,760GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5863EUR$6,074USD£5,029GBP €6514EUR$6,749USD£5,588GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7600EUR$7,874USD£6,519GBP €8445EUR$8,749USD£7,244GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Therapeutic Vaccines Market Report by Type, Disease Type, Technology, Distribution Channel, and Region 2024-2032

Global Therapeutic Vaccines Market by Vaccines Type (Auto-Immune Diseases Vaccines, Chronic Disease Vaccines, Infectious Diseases Vaccines), Disease Indication (Dengue, DTP, Hepatitis), Administration, End-User - Forecast 2024-2030

Global Infectious Vaccines Market by Product (Preventive Vaccine, Therapeutic Vaccine), Infectious Disease (Allergy, Cervical Cancer, DTP), End User - Forecast 2024-2030

Therapeutic Vaccines - Global Strategic Business Report

Vaccine Vials Market by Report Type (Multi Dose, Single Dose), Material (Glass, Polymer), Capacity (10ml, 20ml, 2ml, 3ml, 5ml), Application (Preventive Vaccine, Therapeutic Vaccine), and Region 2024-2032